Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Portrayal of the complex molecular landscape of multidrug resistance in gastric cancer: Unveiling the potential targets

29 Apr 2025

Abstract excerpt

Gastric cancer (GC) is an aggressive malignancy among all Gastrointestinal cancer (GIC) types. Worldwide, among all cancer types, gastric cancer incidence and related mortality remain in fifth position. Multidrug resistance (MDR) in GC presents a major challenge to chemotherapy, and it significantly affects patient survival. A better understanding of the dynamic interaction of cellular factors contributing to MDR...

Topics

Join the communities discussing this publication.

Cholangiocarcinoma and Gallbladder Cancer Studies
Drug Transport and Resistance Mechanisms
MicroRNA in disease regulation

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 40306607
DOI: 10.1016/j.yexcr.2025.114580

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Portrayal of the complex molecular landscape of multidrug resistance in gastric cancer: Unveiling the potential targetsPMID 40306607Read ↗

Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challengesSemantic proximity Read ↗

Molecular Bases of Mechanisms Accounting for Drug Resistance in Gastric AdenocarcinomaSemantic proximity Read ↗

Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug ResistanceSemantic proximity Read ↗

Long Non-Coding RNAs in Drug Resistance of Gastric Cancer: Complex Mechanisms and Potential Clinical ApplicationsSemantic proximity Read ↗

miR‑1 reverses multidrug resistance in gastric cancer cells via downregulation of sorcin through promoting the accumulation of intracellular drugs and apoptosis of cellsSemantic proximity Read ↗

LncRNA DANCR accelerates the development of multidrug resistance of gastric cancer.Semantic proximity Read ↗

Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer CellsSemantic proximity Read ↗

Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancersSemantic proximity Read ↗

The Role of Autophagy in Gastric Cancer Chemoresistance: Friend or Foe?Semantic proximity Read ↗

Drug Resistance in Hepatocellular Carcinoma: Theoretical Basis and Therapeutic AspectsSemantic proximity Read ↗

Notch 1 promotes cisplatin-resistant gastric cancer formation by upregulating lncRNA AK022798 expressionSemantic proximity Read ↗

P-glycoprotein (P-gp)-driven cancer drug resistance: biological profile, non-coding RNAs, drugs and nanomodulatorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.